Publications and Abstracts

Radiosynthesis of clinical doses of 68Ga-DOTATATE (GalioMedix™) and validation of organic-matrix-based 68Ge/68Ga generators

June 14th, 2015|Comments Off on Radiosynthesis of clinical doses of 68Ga-DOTATATE (GalioMedix™) and validation of organic-matrix-based 68Ge/68Ga generators

Izabela Tworowska, David Ranganathan, Sanjay Thamake, Ebrahim Delpassand, Alireza Mojtahedi, Michael K. Schultz, Konstantin Zhernosekov, Sebastian Marx, Nuclear Medicine and Biology, 2015, In Press, Available on-line September 1

An increasing role for 68Ga PET Imaging: A perspective on the availability of parent 68Ge material for generator manufacturing in an expanding market

October 30th, 2012|Comments Off on An increasing role for 68Ga PET Imaging: A perspective on the availability of parent 68Ge material for generator manufacturing in an expanding market

Michael K Schultz, Patrick Donahue, Nannette I Musgrave, Konstantin Zhernosekov, Clive Naidoo, Anatolii Razbash, Izabella Tworowska, David W Dick, G Leonard Watkins, Michael M Graham, Wolfgang Runde, Jeffrey A Clanton, John J Sunderland JAYPEE JOURNAL, [...]

68Ga-labeled PSMA-targeting carbon nanotubes

October 14th, 2012|Comments Off on 68Ga-labeled PSMA-targeting carbon nanotubes

Izabela Tworowska, Sangeeta Ray, Sara Zamanian, Ebrahim Delpassand, Yuri Mackeyev, Lon Wilson, and Martin Pomper, J. Nucl. Med. 2012, 53, 1568, (Supp 1)

Imaging metabolic pathways in cancer cells

October 1st, 2012|Comments Off on Imaging metabolic pathways in cancer cells

S.Thamake, D. Ranganathan, E.S.Delpassand, I. Tworowska; Conference “Discovery on Target” organized by Cambridge Healthtech Institute on October 1st, 2012 in Boston, MA.

Detection of canonical hedgehog signaling in breast cancer by 131-Iodine-labeled derivatives of the sonic hedgehog protein

May 14th, 2012|Comments Off on Detection of canonical hedgehog signaling in breast cancer by 131-Iodine-labeled derivatives of the sonic hedgehog protein

J. Sims-Mourtada, D. Yang, I. Tworowska, R. Larson, D. Smith, N. Tsao, L. Opdenaker, F. Mourtada, and W. Woodward Journal of Biomedicine and Biotechnology, May 2012

Carbon nanotubes modified with sonic-hedgehog ligand

October 14th, 2011|Comments Off on Carbon nanotubes modified with sonic-hedgehog ligand

I. Tworowska, J. Sims-Mourtada, D. Yang, F. Mourtada, E. Delpassand, Y. Mackeyev, L.J.Wilson; J. Nucl. Med., 2011, 52 (Supp 1): 1479.

Survival of patients with disseminated neuroendocrine tumors following multiple cycles of high activity 111In-pentetreotide: Can pretreatment FDG status be a predictive factor?

October 14th, 2011|Comments Off on Survival of patients with disseminated neuroendocrine tumors following multiple cycles of high activity 111In-pentetreotide: Can pretreatment FDG status be a predictive factor?

R. Sharif, J. Sims-Mourtada, I. Tworowska, E. Delpassand; J. Nucl. Med.,2011, 52 (Supp 1): 1312.

Hedgehog derivatives for tumor imaging

February 14th, 2010|Comments Off on Hedgehog derivatives for tumor imaging

I. Tworowska, E. Delpassand, F. Mourtada, S. Ray, M. Pomper, and J. Sims-Mourtada J. Nucl Med., 2010; 51 (Supp 2): 484.

Long-term survival and toxicity profile of patients with disseminated neuroendocrine tumors following multiple cycles of high activity 111In pentetreotide therapy

January 14th, 2010|Comments Off on Long-term survival and toxicity profile of patients with disseminated neuroendocrine tumors following multiple cycles of high activity 111In pentetreotide therapy

E. S. Delpassand, R. Sharif, J. Sims-Mourtada, I. Tworowska, L. B. Anthony J. Clin. Oncol. 28, 2010 (Suppl; abstr e13545)

S.Thamake, D. Ranganathan, E.S.Delpassand, I. Tworowska;  Conference “Discovery on Target” organized by Cambridge Healthtech Institute on October 1st, 2012 in Boston, MA.

Detection of canonical hedgehog signaling in breast cancer by 131-Iodine-labeled derivatives of the sonic hedgehog protein

J. Sims-Mourtada, D. Yang, I. Tworowska, R. Larson, D. Smith, N. Tsao, L. Opdenaker, F. Mourtada, and W.  Woodward    Journal of  Biomedicine and Biotechnology, May 2012

68Ga-labeled click conjugate targeting GLUT1-transporters

Izabela Tworowska, Sara Zamanian, Ebrahim Delpassand, and Michael Schultz, J. Nucl. Med. 2012, 53, 1568 (Supp 1)

68Ga-labeled PSMA-targeting carbon nanotubes

Izabela Tworowska, Sangeeta Ray, Sara Zamanian, Ebrahim Delpassand, Yuri Mackeyev, Lon Wilson, and Martin Pomper, J. Nucl. Med. 2012, 53, 1568,  (Supp 1)

Characterization of organic matrix-based 68Ge/68Ga generators

Izabela Tworowska, Sara Zamanian, and Ebrahim Delpassand; J. Nucl. Med. 2012, 53,  1474, (Supp 1)

Application of click chemistry in the synthesis of 68Ga-labeled agents

I. Tworowska, J. Sims-Mourtada, E. Delpassand; J. Nucl. Med., 2011, 52 (Supp 1): 1528.

Carbon nanotubes modified with sonic-hedgehog ligand

I. Tworowska, J. Sims-Mourtada, D. Yang, F. Mourtada, E. Delpassand, Y. Mackeyev, L.J.Wilson; J.  Nucl. Med., 2011, 52 (Supp 1): 1479.

Survival of patients with disseminated neuroendocrine tumors following multiple cycles of high activity 111In-pentetreotide: Can pretreatment FDG status be a predictive factor?

R. Sharif, J. Sims-Mourtada, I. Tworowska, E. Delpassand; J. Nucl. Med.,2011, 52 (Supp 1): 1312.

Molecular Imaging of Hedgehog Induced Epithelial-Stromal Interactions

W. Woodward, J. Sims-Mourtada, D. Yang, I. Tworowska, R. Larson, D. Smith, F. Mourtada; 34th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 6–10, 2011

Radiolabeled Sonic Hedgehog as a ligand targeting cancer stem cells

I. Tworowska , J. Sims-Mourtada, E. Delpassand; ACS  National Meeting, Boston MA, 2010, August 22-26th

Synthesis of new radiopharmaceuticals for PET imaging by “click chemistry”

I. Tworowska, J. Sims-Mourtada, E. Delpassand; ACS  National Meeting, Boston MA, 2010, August 22-26th

Nanotubes as radiopharmaceuticals for cancer imaging and therapy

Y. Mackeyev, J. Sims-Mourtada, L. J. Wilson, I. Tworowska; ACS  National Meeting, Boston MA, 2010, August 22-26th

Imaging of cancer stem cells using radiolabeled Hedgehog

I. Tworowska, J. Li, F. Mourtada, W. Woodward, J. Mourtada; AACR Annual Meeting, April 17th-21st, 2010

Hedgehog derivatives for tumor imaging

I. Tworowska, E. Delpassand, F. Mourtada, S. Ray, M. Pomper, and J. Sims-Mourtada

J.  Nucl Med., 2010; 51 (Supp 2): 484.

One-pot radiolabeling and purification of tracers on solid-phase”

I. Tworowska, J. Sims-Mourtada, E. S. Delpassand, Bungoo Y., Pagel M.

J. Nucl Med. 2010; 51 (Supp 2):376

Automated manufacturing of clinical-grade 177Lu- labeling DOTA0-Tyr3-octreotate using SmarTrace

I. Tworowska, J. Simon, J. Sims-Mourtada, F. Mourtada, and E. Delpassand

J. Nucl Med. 2010; 51(Supp 2): 1551.

Long-term evaluation of renal toxicity with multiple doses of high activity 111In-pentetreotide in patients with disseminated neuroendocrine tumors

R. Sharif, J. Sims-Mourtada, I. Tworowska, and E. Delpassand

J. Nucl Med.,  2010; 51(Supp 2): 1158.

Long-term survival and toxicity profile of patients with disseminated neuroendocrine tumors following multiple cycles of high activity 111In pentetreotide therapy

E. S. Delpassand, R. Sharif, J. Sims-Mourtada, I. Tworowska, L. B. Anthony

J. Clin. Oncol. 28, 2010 (Suppl; abstr e13545)